Results 181 to 190 of about 23,301 (196)

Limited-stage mantle-cell lymphoma

Annals of Oncology, 2003
Randy Gascoyne, R Klasa, R D Gascoyne
exaly  

Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

Annals of Oncology, 2002
, Yukio Kobayashi, Y Matsuno
exaly  

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

New England Journal of Medicine, 2018
Sasanka Handunnetti, Rodney Hicks, Mary Ann Anderson   +2 more
exaly  

Management of mantle cell lymphoma

Annals of Hematology, 1999
P, Meusers, J, Hense
openaire   +2 more sources

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

New England Journal of Medicine, 2015
Peter Martin, Jakub Svoboda, Sonali Smith   +2 more
exaly  

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Annals of Oncology, 2009
Benjamin Djulbegovic, J P Leonard, A Goy   +2 more
exaly  

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of Oncology, 2015
Dai Chihara, Richard Champlin, John Seymour   +2 more
exaly  

Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?

Annals of Oncology, 2002
Fernando Cabanillas, Issa Khouri, Jorge Romaguera   +2 more
exaly  

Central nervous system involvement in mantle cell lymphoma

Annals of Oncology, 2008
Francesc Bosch
exaly  

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

New England Journal of Medicine, 2015
Juliana Pereira, , Evgenii Osmanov
exaly